Here are three things to know:
1. The Sprint System is the only percutaneous PNS system cleared by the FDA. It is indicated for up to 60 days in the spine and extremities for chronic and acute pain.
2. The platform offers:
- Dual lead capability to allow physicians to implant two leads connected to a single wearable pulse generator
- Rechargeable batteries for continuous stimulation delivery
- A Bluetooth-enabled controller for patient-specific customization
3. The Sprint PNS System is designed to provide a non-opioid therapy alternative.
“In my experience, most patients prefer a non-permanent, non-destructive and nonsurgical option for pain management when possible,” said pain management physician Chris Gilmore, MD. “The minimally invasive nature of the Sprint System allows us to introduce peripheral nerve stimulation therapy early in the care continuum, including its use in well-selected patients with back pain.”
More articles on devices:
How 8 big spine companies’ Q2 compared & what to expect in the future
KFx Medical sues Stryker for patent infringement; Arthrex paid $35M in similar suit: 4 key notes
NuVasive appoints new vice president of manufacturing: 3 things to know
